Gilead’s Veklury received conditional marketing authorization from the European Commission Gilead Sciences has announced that the European Commission has granted conditional marketing authorization for Veklury (remdesivir) for t...
Janssen’s COVID-19 vaccine trial to begin in second half of July Janssen announced that it would accelerate the development of COVID-19 vaccine development. The press statement said that it accelerated ...
Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit The Global Vaccine Summit hosted in the UK was successful in raising US$ 8.8 billion, more than the expected target of US$ 7.4 billion. T...
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients Gilead has announced top-line Phase 3 trial results of remdesivir in patients with COVID-19. The drug is indicated in moderate COVID-19 p...
EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation European Medicines Agency’s Human Medicines Committee has recommended the use of remdesivir in COVID-19 patients who were not on mechanic...
Gilead’s Veklury (remdesivir) approved by Japan’s MHLW for COVID-19 Gilead has announced that the Japanese Ministry of Health, Labor and Welfare approved Veklury (remdesivir) for severe COVID-19. The drug ...
PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE Pfizer and BioNTech have announced that the first participant was administered with the vaccine in the Phase ½ trial. The trial was star...
J&J announces lead vaccine for COVID-19, commits to provide one billion vaccines worldwide Johnson & Johnson has announced today that along with Biomedical Advanced Research and Development Authority (BARDA), the company will in...
